Bridgebio Pharma Inc logo

BBIO

Bridgebio Pharma Inc

$26.8

Earnings Summary

Revenue
$211.12Mn
Net Profits
$-35.22Mn
Net Profit Margins
-16.68%

Highlights

Revenue:

Bridgebio Pharma Inc’s revenue jumped 11461.88% since last year same period to $211.12Mn in the Q1 2024. On a quarterly growth basis, Bridgebio Pharma Inc has generated 11998.57% jump in its revenue since last 3-months.

Net Profits:

Bridgebio Pharma Inc’s net profit jumped 80.09% since last year same period to $-35.22Mn in the Q1 2024. On a quarterly growth basis, Bridgebio Pharma Inc has generated 79.06% jump in its net profits since last 3-months.

Net Profit Margins:

Bridgebio Pharma Inc’s net profit margin jumped 99.83% since last year same period to -16.68% in the Q1 2024. On a quarterly growth basis, Bridgebio Pharma Inc has generated 99.83% jump in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Bridgebio Pharma Inc post its latest quarter earnings

EPS Estimate Current Year
-0.89

Highlights

EPS Estimate Current Year:

Bridgebio Pharma Inc’s earning per share (EPS) estimates for the current year stand at -0.89.

Key Ratios

Key ratios of the Bridgebio Pharma Inc post its Q1 2024 earnings

Earning Per Share (EPS)
-0.2
Return on Assets (ROA)
-0.4
Return on Equity (ROE)
-17.9

Highlights

Earning Per Share (EPS):

Bridgebio Pharma Inc’s earning per share (EPS) jumped 78.26% since last year same period to -0.2 in the Q1 2024. This indicates that the Bridgebio Pharma Inc has generated 78.26% annual rate of jump in its earning per share (EPS) in the last 4 quarters.

Return on Assets (ROA):

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Bridgebio Pharma Inc’s return on assets (ROA) stands at -0.4.

Earning Per Share (EPS):

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Bridgebio Pharma Inc’s return on equity (ROE) stands at -17.9.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2024-05-02
-0.71
-0.2
71.83%

Discover More Earning Stocks in Health Technology Sector